PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 109 filers reported holding PULMONX CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $8 | -27.3% | 1,187 | 0.0% | 0.00% | – |
Q1 2024 | $11 | -83.3% | 1,187 | -76.9% | 0.00% | -100.0% |
Q4 2023 | $66 | +15.8% | 5,143 | -6.4% | 0.00% | – |
Q3 2023 | $57 | -20.8% | 5,496 | 0.0% | 0.00% | -100.0% |
Q2 2023 | $72 | +35.8% | 5,496 | +15.2% | 0.00% | – |
Q1 2023 | $53 | +15.2% | 4,771 | -13.1% | 0.00% | – |
Q4 2022 | $46 | -99.9% | 5,488 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $91,000 | +13.8% | 5,488 | +1.6% | 0.00% | 0.0% |
Q2 2022 | $80,000 | -23.8% | 5,403 | +27.1% | 0.00% | 0.0% |
Q1 2022 | $105,000 | -50.5% | 4,251 | -11.4% | 0.00% | -50.0% |
Q2 2021 | $212,000 | – | 4,797 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
Yu Fan | 303,030 | $13,861,000 | 36.18% |
ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
Miura Global Management | 405,000 | $18,525,000 | 3.31% |
GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |